-
Molly Brakhane
-
Marlene Campos Guerrero
Investigating the role of Squamous Cell Carcinoma Antigen 1 (SCCA1), in cervical cancer tumor microenvironment.
-
Julius Chembo
Discovering and validating pharmacological/ therapeutic inhibitors of NRF2 in Lung, Head and Neck Cancers
-
Pei Yu Chen
To investigate the role of ARID2 in melanoma.
-
Jessica Devenport
Investigating the role of APOBEC3A in tumor progression and clonal evolution
-
Rachel DeWeerd
Identifying the pro-survival functions of BIRC5 in T-ALL cells compared to normal healthy cells to inform the design of inhibitors.
-
Alessandra DiMauro
Determining functional roles of CAF subtypes in leader cell directed collective migration
-
Haley Jane Hashemi Hashemi
I am currently investigating the activity and stability of A3A isoforms, and how this may play a role in cancer associated DNA damage.
-
Omar Ibrahim
Immunomodulation of the tumor microenvironment
-
Darya Khantakova
Innate immune cells in the tumor microenvironment
-
Tim Kong (MSTP in PhD training)
Pevonedistat target malignant cells in myeloproliferative neoplasms via NF-kB-pathway inhibition
-
Aishwarya Krishnan
Understanding how APOBEC3A impacts transcript stability
-
Jie Liu
Characterization of Genetic Predisposition to Clonal Hematopoiesis and Progression to Myeloid Neoplasms
-
Alex Mabry
Modulating membrane receptor availability to improve antibody based therapies.
-
Hung Mai
Characterization of circular RNA functions in colorectal cancers
-
Camryn Marquez
Determine the role of fibroblast subpopulations associated with cancer in promoting angiogenesis and evaluate senescence's effect on gene expression.
-
Isabelle Seppa
My research is focused on what factors mediate MRE11 activity in single-stranded gap processing during the DNA damage response process.
-
Judith Sokei
Understanding metabolic reprogramming in gynecological cancers with a focus on high grade serous ovarian (HGSOC) and the role/effect of GAS6/AXL signaling as a therapeutic strategy.
-
Luisangely Soto Torres
-
Infencia Xavier Raj
Understanding how JARID2 works independent of PRC2.